Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Kulvait
    Member
    • Aug 2012
    • 11

    RNA-seq experiment design

    Hi,
    we have mouse models with knock out of some genes. Basically we have at least 3 different mouse genotypes with additional problems with variability of potential biological multiplicates in a genotype group (male/female, relatives, age). We are considering RNAseq that we has not done before so my group have no experience in it. Any help in the design phase will be highly appreciated.

    We would like to perform RNA-seq in order to answer these questions:
    • How the knock out genes affect resulting rna transcripts forms?
    • Are there also differences in rRNA or microRNA?
    • We are partly interested in differential mRNA expression.


    I would like to ask on this forum few questions regarding experimental design.
    • Do you think that sequencing whole RNA and not only mRNA is reasonable? What to expect if we do that? Do you have experience with that and are there some analytical approaches for such data?
    • We will have paired end rapid run sequencing on Illumina Hi-Seq 2000. What the sequencing depth should be? And if we want to achieve given sequencing depth (i.e. 1000x) how much sequencing capacity should we allocate per sample?
    • Is it sufficient to have biological replicates or technical replicates are also needed? If we have three genotypes how many samples per genotype is sufficient to perform any meaningful analysis of differential transcript forms in different genotypes?


    Thank you for answers,
    Vojtech.
    Last edited by Kulvait; 09-13-2017, 04:09 AM.
    Data analysis www.persmed.eu
  • Genetic Librarian
    Member
    • May 2017
    • 31

    #2
    Hi Voijtech,

    first, I would recomment you to read this for some more background:

    This guide covers fundamentals of NGS technology and design of sequencing experiments. Topics include depth of coverage, read length and multiplexing.


    Second: Getting good data for miRNA, rRNA and mRNA in a single experiment is not reasonable.

    If you sequence total RNA, 98% of your reads will be rRNAs.
    In my opinion, you would need three library types (miRNA, total RNA without enrichment and mRNA) to check for all types.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Working...